Key Takeaways
- A roughly 12% price swing in BBWI stock is being anticipated by options market participants after Q2 results arrive August 26
- Analysts project earnings per share of $0.24, representing a decline from the $0.37 reported in the year-ago quarter, while revenue is estimated at $1.5 billion
- Year-to-date, BBWI stock has declined approximately 2%, though shares have rebounded 8% during the past three-month period
- Trading within a 52-week span of $14.28 to $32.32, the stock carries a beta coefficient of 1.38
- Analyst sentiment leans toward Moderate Buy with a mean price objective of $23.55, suggesting potential upside of 23%
The upcoming Q2 financial results from Bath & Body Works, scheduled for August 26, have options market participants anticipating substantial price movement. The derivatives market suggests an expected swing of approximately 11.42% in either direction following the announcement.
Trading near $19.38, BBWI stock shows a modest year-to-date decline of roughly 2%. However, recent momentum has been more favorable, with shares advancing approximately 8% across the trailing three-month window.
Historical earnings reactions for the company demonstrate considerable variance. Following the most recent quarterly announcement on May 27, 2026, shares surged 9.70%. In stark contrast, the November 2025 report triggered a steep 24.81% selloff. Such swings underscore the inherent volatility surrounding BBWI.
For the second quarter, Wall Street’s consensus projects earnings of $0.24 per share, marking a significant decrease from the $0.37 delivered in the comparable period last year. Sales are anticipated to reach approximately $1.5 billion, falling marginally below the prior year’s $1.54 billion.
Given the company’s track record of falling short on revenue projections repeatedly throughout the previous two years, this metric will draw particular scrutiny from market observers.
Key Metrics Under Analyst Scrutiny
The projected revenue figure represents a year-over-year contraction of roughly 3.4% for the quarter. This marks a notable shift from the positive 1.5% expansion achieved in last year’s second quarter, establishing a more cautious framework for the upcoming release.
Estimate revisions among BBWI analysts have remained relatively static during the last 30 days, indicating limited expectation of dramatic developments. Nevertheless, the specialty retail landscape has demonstrated considerable unpredictability in recent months.
Comparable companies within the segment have delivered divergent outcomes. Warby Parker achieved 9.8% top-line growth yet experienced a 9.6% post-earnings decline. Meanwhile, Sally Beauty reported unchanged revenue and rallied 10.6%. Such mixed signals have created heightened anxiety among sector investors.
Company leadership has implemented initiatives to counteract weakening consumer demand patterns. Among these efforts is a newly established strategic collaboration with Ulta Beauty, designed to enhance customer traffic and boost sales performance.
Commentary around consumer spending dynamics will likely dominate the earnings conference call. Market participants are eager to understand management’s assessment of the purchasing environment as the company navigates the second half of the fiscal year.
Analyst Ratings and Price Objectives
TipRanks data reveals a Moderate Buy consensus derived from 4 Buy recommendations, 6 Hold ratings, and 1 Sell rating. The mean analyst price target reaches $23.55, indicating approximately 23% potential appreciation from present trading levels.
The most optimistic price objective on Wall Street sits at $30. While substantially above current valuations, this bullish forecast reflects confidence among certain analysts that recovery is achievable if operational fundamentals stabilize.
Over the trailing 52 weeks, Bath & Body Works stock has fluctuated within a range spanning $14.28 to $32.32. The elevated beta reading of 1.38 indicates amplified sensitivity to market movements compared to broader indices, consistent with the options market’s implied volatility of 12%.
Entering the earnings event, BBWI stock has retreated 5.4% during the past month, lagging the specialty retail sector benchmark which has advanced 1.6% over the identical timeframe.
The consensus analyst price target of $25.33 stands in notable contrast to the current market price of $19.38.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
